Trustlife as an Innovative Health Technologies Platform: A Transformative and Collective Business Model
In our blog post, Trustlife CEO Dr. Bülent Denkdemir presents a long-term, collective, and science-driven approach that differs from traditional investment models. Leveraging artificial intelligence, multi-omics data, strong R&D infrastructure, and disciplined portfolio management, Trustlife aims to transform drug development while creating sustainable value for both human health and investors.
